Company intelligence / Profile preview

Natural Pharma International

Lugano, Ticino, Switzerland

Ownership: Private
Development stage: Other

Overview

Natural Pharma International (NPI) is a Swiss-based biopharmaceutical company dedicated to the development of innovative therapies for rare neurodegenerative and ophthalmic diseases. The company's lead candidate, NPI-001, is a high-purity pharmaceutical formulation of tauroursodeoxycholic acid (TUDCA) aimed at treating Retinitis Pigmentosa and Usher Syndrome. NPI-001 functions as a chemical chaperone that reduces endoplasmic reticulum stress and prevents apoptosis in photoreceptor cells, thereby preserving visual function. The company has received Orphan Drug Designation for NPI-001 from both the U.S. FDA and the European Medicines Agency. NPI focuses on bridging the gap between natural substances and modern pharmaceutical standards through rigorous R&D and clinical validation.

Therapeutic areas: OphthalmologyRare Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Natural Pharma International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural Pharma International.

Explore the full profile